A Study of CDX-585 in Patients With Advanced Malignancies

Clinical trial NCT05788484 · COMPLETED

Trial details

NCT number: NCT05788484
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Gastric Cancer Head and Neck Cancer Ovarian Cancer Primary Peritoneal Carcinoma Fallopian Tube Cancer Bladder Urothelial Carcinoma Colorectal Cancer Esophageal Cancer Hepatic Cancer Renal Cell Carcinoma Cholangiocarcinoma

Start date: 2023-05-11
Primary completion: 2025-05-21
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.